Iradimed Corporation (NASDAQ:IRMD) Sees Large Growth in Short Interest

Iradimed Corporation (NASDAQ:IRMD) saw a significant growth in short interest in November. As of November 15th, there was short interest totalling 85,900 shares, a growth of 6.3% from the October 31st total of 80,800 shares. Currently, 1.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 42,300 shares, the short-interest ratio is currently 2.0 days.

Insider Buying and Selling at Iradimed

In other news, CFO John Glenn sold 2,500 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total transaction of $135,450.00. Following the transaction, the chief financial officer now directly owns 4,383 shares in the company, valued at $237,470.94. The trade was a 36.32 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 37.10% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Iradimed

A number of large investors have recently bought and sold shares of IRMD. Liontrust Investment Partners LLP bought a new stake in Iradimed in the second quarter worth $2,830,000. Charles Schwab Investment Management Inc. lifted its position in Iradimed by 189.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 66,632 shares of the medical equipment provider’s stock worth $3,351,000 after acquiring an additional 43,635 shares during the last quarter. Oak Ridge Investments LLC acquired a new position in Iradimed during the 3rd quarter worth $2,188,000. Eagle Asset Management Inc. acquired a new position in Iradimed during the 3rd quarter worth $1,239,000. Finally, Kings Path Partners LLC acquired a new position in shares of Iradimed during the second quarter valued at about $1,055,000. 92.34% of the stock is currently owned by institutional investors.

Iradimed Stock Up 2.0 %

Iradimed stock opened at $54.72 on Thursday. The company’s fifty day simple moving average is $51.90 and its 200-day simple moving average is $47.41. Iradimed has a 12 month low of $40.18 and a 12 month high of $57.95. The stock has a market cap of $693.47 million, a P/E ratio of 37.48 and a beta of 0.82.

Iradimed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Friday, November 15th were issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date of this dividend was Friday, November 15th. Iradimed’s dividend payout ratio is presently 41.10%.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.